格隆汇1月10日丨东富龙(300171.SZ)公布，公司于2023年1月10日召开第五届董事会第二十二次(临时)会议和第五届监事会第二十一次(临时)会议，分别审议通过《关于使用募集资金向全资子公司增资以实施募投项目的议案》，同意公司使用募集资金向全资子公司浙江东富龙生物技术有限公司(简称“浙江东富龙”)增资8.60亿元，其中股本1.00亿元，资本公积7.60亿元，增资完成后浙江东富龙注册资本为2.00亿元；向全资子公司东富龙智能装备制造(江苏)有限公司(简称“东富龙江苏”)增资6.20亿元，其中股本1.00亿元，资本公积5.20亿元，增资完成后东富龙江苏注册资本为3.00亿元。
Risk disclosure: The above content only represents the opinion of the authors or guests, and does not represent any positions of Futu or constitute any investment advice on the part of Futu. Before making any investment decision, investors should consider the risk factors related to investment products based on their own circumstances and consult professional investment advisers where necessary. Futu makes every effort to verify the authenticity, accuracy, and originality of the above content, but does not make any guarantees or promises.
